Login / Signup

The Risk of Developing Long COVID in Patients with Inflammatory Bowel Diseases: Do Immunosuppressive Drugs Matter?

Arno R BourgonjeAntonius T Otten
Published in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • respiratory syndrome coronavirus
  • drug induced